Marks & Spencer Group plc buy krebskrebs
Start price
29.06.20
/
50%
€1.13
Target price
04.11.21
€1.40
Performance (%)
99.82%
End price
05.11.21
€2.26
Summary
This prediction ended on 05.11.21 with a price of €2.26. The BUY prediction by krebskrebs for Marks & Spencer Group plc saw massive gains of 99.82%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Marks & Spencer Group plc | 0.948% | 0.948% | -11.947% | 123.857% |
| iShares Core DAX® | 3,59 % | 3,93 % | 15,38 % | 53,20 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % | 41,46 % | 91,09 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % | 48,95 % | 63,93 % |
| iShares S&P 500 | 4,14 % | 4,04 % | 31,59 % | 64,84 % |
Comments by krebskrebs for this prediction
In the thread Marks & Spencer Group plc diskutieren
Buy mit Kursziel 1,4
In the thread Trading Marks & Spencer Group plc
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

